Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ganesharaja Selvaluxmy"'
Publikováno v:
Cellular oncology (Dordrecht). 36(6)
The objective of this study was to determine radiation, doxorubicin, tamoxifen and letrozole sensitivity of breast cancer cells in response to functional inhibition of the ubiquitin conjugating enzyme UBE2C. Taqman Real time PCR was performed to meas
Autor:
Johnjothi, Sam Deva Kumar, Ranganathan, Arulpandiyan, Jayapaul, Vasanth Christopher, Santosham, Rithesh, Rajasekaran, Dhanabalan, Nagarajan, Vivekanandan, Ganesharaja, Selvaluxmy
Publikováno v:
Polish Journal of Medical Physics And Engineering; June 2019, Vol. 25 Issue: 2 p111-119, 9p
Publikováno v:
International journal of radiation biology. 88(9)
To find the radiation sensitivity of human cervical carcinoma cell lines and to investigate the effect of the dominant negative-Ubiquitin-conjugating enzyme E2C (DN-UBE2C) on cell proliferation and radiation response.Radiation sensitivities of human
Autor:
Ganesharaja Selvaluxmy, Neelakantan Vijayalakshmi, Sundersingh Shirley, Kesavan Sabitha, Thangarajan Rajkumar, Mayil Vahanan Bose, Gopisetty Gopal
Publikováno v:
BMC Cancer, Vol 11, Iss 1, p 80 (2011)
BMC Cancer
BMC Cancer
Background Cervical cancer is the most common cancer among Indian women. This cancer has well defined pre-cancerous stages and evolves over 10-15 years or more. This study was undertaken to identify differentially expressed genes between normal, dysp
Publikováno v:
Indian Journal of Gynecologic Oncology; March 2019, Vol. 17 Issue: 1 p1-2, 2p
Autor:
Neelakantan Vijayalakshmi, Lavanya Nambaru, Mayil Vahanan Bose, Sundersingh Shirley, Thangarajan Rajkumar, Kesavan Sabitha, Ganesharaja Selvaluxmy
Publikováno v:
BMC Cancer
BMC Cancer, Vol 9, Iss 1, p 365 (2009)
BMC Cancer, Vol 9, Iss 1, p 365 (2009)
Background Cervical cancer is the most common cancer among Indian women. The current recommendations are to treat the stage IIB, IIIA, IIIB and IVA with radical radiotherapy and weekly cisplatin based chemotherapy. However, Radiotherapy alone can hel
Autor:
Bose M; Department of Molecular Oncology, Cancer Institute (WIA), Chennai, India., Sunder Singh S; Department of Onco-Pathology, Cancer Institute (WIA), 38, Sardar Patel Road, Guindy, Chennai, India., Ganesharaja S; Department of Radiation Oncology, Cancer Institute, Chennai, 600 036 Tamil Nadu, India., Chiwate AS; Cervical Cancer Prevention Programme, Nargis Dutt Memorial Cancer Hospital Barshi, Maharahstra, India., Hingmire SJ; Cervical Cancer Prevention Programme, Nargis Dutt Memorial Cancer Hospital Barshi, Maharahstra, India., Rajkumar T; Department of Molecular Oncology, Cancer Institute (WIA), Chennai, India.
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2023 Jul 01; Vol. 24 (7), pp. 2337-2346. Date of Electronic Publication: 2023 Jul 01.